IS8612A - Stöðugar statínlyfjasamsetningar - Google Patents

Stöðugar statínlyfjasamsetningar

Info

Publication number
IS8612A
IS8612A IS8612A IS8612A IS8612A IS 8612 A IS8612 A IS 8612A IS 8612 A IS8612 A IS 8612A IS 8612 A IS8612 A IS 8612A IS 8612 A IS8612 A IS 8612A
Authority
IS
Iceland
Prior art keywords
stable statin
statin formulations
formulations
stable
statin
Prior art date
Application number
IS8612A
Other languages
English (en)
Inventor
Jóhannsson Fjalar
Original Assignee
Actavis Group Ptc Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Group Ptc Ehf. filed Critical Actavis Group Ptc Ehf.
Priority to IS8612A priority Critical patent/IS8612A/is
Priority to EP08710292A priority patent/EP2124904A1/en
Priority to PCT/IS2008/000006 priority patent/WO2008102379A1/en
Publication of IS8612A publication Critical patent/IS8612A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS8612A 2007-02-19 2007-02-19 Stöðugar statínlyfjasamsetningar IS8612A (is)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IS8612A IS8612A (is) 2007-02-19 2007-02-19 Stöðugar statínlyfjasamsetningar
EP08710292A EP2124904A1 (en) 2007-02-19 2008-02-19 Stable sustained release formulations of fluvastatin
PCT/IS2008/000006 WO2008102379A1 (en) 2007-02-19 2008-02-19 Stable sustained release formulations of fluvastatin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IS8612A IS8612A (is) 2007-02-19 2007-02-19 Stöðugar statínlyfjasamsetningar

Publications (1)

Publication Number Publication Date
IS8612A true IS8612A (is) 2008-08-20

Family

ID=39523591

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8612A IS8612A (is) 2007-02-19 2007-02-19 Stöðugar statínlyfjasamsetningar

Country Status (3)

Country Link
EP (1) EP2124904A1 (is)
IS (1) IS8612A (is)
WO (1) WO2008102379A1 (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104069502B (zh) * 2013-03-29 2018-02-16 北京罗诺强施医药技术研发中心有限公司 复合骨架材料及其药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603667D0 (sv) * 1996-10-08 1996-10-08 Astra Ab Pharmaceutical compositions
US20010006644A1 (en) * 1997-07-31 2001-07-05 David J. Bova Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia once a day at night
US20070275996A1 (en) * 2003-12-16 2007-11-29 Michele Bortolini Use of Statins For The Treatment Of Metabolic Syndrome
KR100598326B1 (ko) * 2004-04-10 2006-07-10 한미약품 주식회사 ＨＭＧ-ＣｏＡ 환원효소 억제제의 경구투여용 서방형 제제및 이의 제조방법

Also Published As

Publication number Publication date
WO2008102379A1 (en) 2008-08-28
EP2124904A1 (en) 2009-12-02

Similar Documents

Publication Publication Date Title
NO2021010I1 (no) telostritat ethyl
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0820381A2 (pt) Formulações farmacêuticas
DK2068886T3 (da) Lipidholdige præparater
BRPI0814003A2 (pt) Formulações de anticorpo
BRPI0814252A2 (pt) Formulações de anticorpo
DK2066354T3 (da) Norovirus vaccine formuleringer
BRPI0814188A2 (pt) Formulações
BRPI0908785A2 (pt) Formulações herbicida
BRPI0721651A2 (pt) Composição farmacêutica
NO20075628L (no) Farmasøytiske formuleringer
BRPI0821831A2 (pt) Compostos inseticidas
BRPI0807453A2 (pt) Preparação sólida
DK3354267T3 (da) Stabiliseret sulforaphan
RU2493831C3 (ru) Фармацевтические композиции
DK2114143T3 (da) Flydende sulfonylurea-herbicidformuleringer
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0820198A2 (pt) composições farmacêuticas
DK2966175T3 (da) Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
DE602007007755D1 (de) Fußplatte
BRPI0817053A2 (pt) Formulações farmacêuticas de orlistat
FR2896414B1 (fr) Composition cosmetique matifiante
BRPI0809653A2 (pt) Formulações líquidas de manoproteína
FR2915896B1 (fr) Composition cosmetique foisonnee
FR2924022B1 (fr) Composition cosmetique tenseur